Stevanato Group (NYSE:STVN) Stock Price Down 5.8%

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) shares were down 5.8% during mid-day trading on Tuesday . The stock traded as low as €21.20 ($22.80) and last traded at €21.27 ($22.87). Approximately 307,550 shares changed hands during trading, a decline of 26% from the average daily volume of 416,272 shares. The stock had previously closed at €22.59 ($24.29).

Analysts Set New Price Targets

A number of research firms have weighed in on STVN. Morgan Stanley reaffirmed an "equal weight" rating and set a $30.00 price target on shares of Stevanato Group in a research note on Monday, April 22nd. Stephens reaffirmed an "overweight" rating and set a $38.00 price target on shares of Stevanato Group in a research note on Monday, March 25th. Finally, BNP Paribas began coverage on shares of Stevanato Group in a research note on Monday, April 22nd. They set an "outperform" rating on the stock. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of €34.29 ($36.87).

Stevanato Group Price Performance

The firm has a market capitalization of $6.31 billion, a price-to-earnings ratio of 38.67, a price-to-earnings-growth ratio of 2.95 and a beta of 0.76. The company's fifty day moving average price is €28.71 and its 200 day moving average price is €28.83. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.35 and a current ratio of 1.92.

Stevanato Group (NYSE:STVN - Get Free Report) last announced its quarterly earnings data on Thursday, May 9th. The company reported €0.09 ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.12 ($0.13) by (€0.03) (($0.03)). Stevanato Group had a return on equity of 12.61% and a net margin of 12.57%. The business had revenue of €256.24 million during the quarter, compared to analyst estimates of €261.28 million. Equities research analysts expect that Stevanato Group S.p.A. will post 0.55 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Bessemer Group Inc. increased its stake in Stevanato Group by 5.7% in the 1st quarter. Bessemer Group Inc. now owns 292,726 shares of the company's stock valued at $9,396,000 after buying an additional 15,831 shares during the period. Thornburg Investment Management Inc. boosted its holdings in shares of Stevanato Group by 14.5% during the 1st quarter. Thornburg Investment Management Inc. now owns 196,840 shares of the company's stock worth $6,319,000 after buying an additional 25,000 shares during the period. Clearbridge Investments LLC boosted its holdings in shares of Stevanato Group by 13.1% during the 1st quarter. Clearbridge Investments LLC now owns 1,729,397 shares of the company's stock worth $55,514,000 after buying an additional 200,753 shares during the period. Lindenwold Advisors INC bought a new stake in shares of Stevanato Group during the 1st quarter worth $324,000. Finally, Jackson Square Partners LLC boosted its holdings in shares of Stevanato Group by 763.9% during the 1st quarter. Jackson Square Partners LLC now owns 1,824,240 shares of the company's stock worth $58,558,000 after buying an additional 1,613,075 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.